May 26, 2021
WASHINGTON – Today, U.S. Senator Roy Blunt (Mo.), the top Republican on the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education and Related Agencies, announced his support for a new institute at the National Institutes of Health (NIH), the Advanced Research Projects Agency for Health (ARPA-H), which would utilize public-private partnerships to dramatically accelerate the development and approval of new treatments and technologies.
During the hearing, Blunt questioned NIH Director Dr. Francis Collins on the appropriate funding level for ARPA-H; National Cancer Institute Director Dr. Ned Sharpless on the impact ARPA-H could have on advancing cancer research; and National Institute of Biomedical Imaging and Bioengineering Director Dr. Bruce Tromberg on how NIH’s experience with the Blunt-backed RADx initiative could serve as a model for future ARPA-H partnerships.